oral semaglutide weight loss studies Now that (#wegovy) is available, people want to know more about how the oral and injectable forms compare. First slide is the trial design. Second slide is average #weightloss of Semaglutide Market Size, Share &

A negative or inconclusive JCA report doesnt block reimbursement Member States retain that authority but it creates a problematic starting point for national HTA bodies

Retrieved from Dunlevy, C., MacLellan, G

Why they matter: Large randomised cardiovascular and renal outcome trials (EMPA-REG OUTCOME, DAPA-HF, DAPA-CKD, EMPEROR-Reduced/Preserved, CREDENCE, EMPA-KIDNEY) consistently showed reductions in heart-failure hospitalisation, progression of chronic kidney disease, and cardiovascular death

Older adults also tend to clear the drug more slowly because age changes in liver and kidney function alter elimination